US Stock MarketDetailed Quotes

CVKD Cadrenal Therapeutics

Watchlist
  • 14.269
  • -3.331-18.93%
Trading Nov 4 15:49 ET
21.36MMarket Cap-2439P/E (TTM)

Cadrenal Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-92.28%-1.53M
-29.98%-1.84M
-3.53M
-694.45K
-627.78K
-795.31K
-3,133.01%-1.41M
-43.7K
Net income from continuing operations
-138.58%-2.39M
67.85%-1.66M
---8.36M
---1.14M
---1.04M
---1M
-2,828.75%-5.17M
---176.65K
Operating gains losses
----
----
--956.23K
--0
--0
--0
62,073.86%956.23K
--1.54K
Depreciation and amortization
-21.14%470
214.21%597
--1.98K
--597
--597
--596
--190
--0
Other non cash items
-216.48%-106
-100.00%-105
--3.01M
--24
--89
--91
120,061.68%3.01M
--2.51K
Change In working capital
1,609.53%670.25K
32.15%-336.32K
--144.31K
--345.88K
--254.92K
--39.21K
-484.55%-495.7K
--128.9K
-Change in prepaid assets
-12.78%58.82K
27.09%-204.09K
---66.96K
--78.93K
--66.59K
--67.44K
-12,588.67%-279.91K
---2.21K
-Change in payables and accrued expense
2,278.52%614.97K
104.00%35.62K
---463.22K
--266.95K
--188.33K
---28.23K
-773.40%-890.27K
--132.21K
-Change in other current assets
--0
--0
--2.2K
---1
--1
---1
300.18%2.2K
---1.1K
-Change in other working capital
---3.54K
-124.97%-167.84K
--672.3K
--0
--0
--0
--672.3K
----
Cash from discontinued investing activities
Operating cash flow
-92.28%-1.53M
-29.98%-1.84M
---3.53M
---694.45K
---627.78K
---795.31K
-3,133.01%-1.41M
---43.7K
Investing cash flow
Cash flow from continuing investing activities
-3.25K
0
-1
Net PPE purchase and sale
----
----
---3.25K
--0
---1
----
----
----
Cash from discontinued investing activities
Investing cash flow
----
----
---3.25K
--0
---1
----
----
----
Financing cash flow
Cash flow from continuing financing activities
0
-99.99%298
11.9M
-12.5K
6.51M
0
968.80%5.41M
506.04K
Net issuance payments of debt
--0
--0
---250K
--0
--0
--0
-150.15%-250K
--498.54K
Net common stock issuance
--0
--0
--11.9M
---12.5K
--6.51M
--0
72,014.33%5.41M
--7.5K
Proceeds from stock option exercised by employees
--0
-99.88%298
--250K
--0
--0
--0
--250K
----
Cash from discontinued financing activities
Financing cash flow
--0
-99.99%298
--11.9M
---12.5K
--6.51M
--0
968.80%5.41M
--506.04K
Net cash flow
Beginning cash position
63.00%6.57M
25,685.61%8.4M
--32.59K
--9.11M
--3.23M
--4.03M
--32.59K
--0
Current changes in cash
-91.50%-1.53M
-145.95%-1.84M
--8.37M
---706.95K
--5.88M
---798.56K
764.25%4M
--462.34K
End cash Position
55.96%5.04M
63.00%6.57M
--8.4M
--8.4M
--9.11M
--3.23M
771.30%4.03M
--462.34K
Free cash flow
-91.50%-1.53M
-29.98%-1.84M
---3.53M
---694.45K
---627.78K
---798.56K
-3,133.01%-1.41M
---43.7K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -92.28%-1.53M-29.98%-1.84M-3.53M-694.45K-627.78K-795.31K-3,133.01%-1.41M-43.7K
Net income from continuing operations -138.58%-2.39M67.85%-1.66M---8.36M---1.14M---1.04M---1M-2,828.75%-5.17M---176.65K
Operating gains losses ----------956.23K--0--0--062,073.86%956.23K--1.54K
Depreciation and amortization -21.14%470214.21%597--1.98K--597--597--596--190--0
Other non cash items -216.48%-106-100.00%-105--3.01M--24--89--91120,061.68%3.01M--2.51K
Change In working capital 1,609.53%670.25K32.15%-336.32K--144.31K--345.88K--254.92K--39.21K-484.55%-495.7K--128.9K
-Change in prepaid assets -12.78%58.82K27.09%-204.09K---66.96K--78.93K--66.59K--67.44K-12,588.67%-279.91K---2.21K
-Change in payables and accrued expense 2,278.52%614.97K104.00%35.62K---463.22K--266.95K--188.33K---28.23K-773.40%-890.27K--132.21K
-Change in other current assets --0--0--2.2K---1--1---1300.18%2.2K---1.1K
-Change in other working capital ---3.54K-124.97%-167.84K--672.3K--0--0--0--672.3K----
Cash from discontinued investing activities
Operating cash flow -92.28%-1.53M-29.98%-1.84M---3.53M---694.45K---627.78K---795.31K-3,133.01%-1.41M---43.7K
Investing cash flow
Cash flow from continuing investing activities -3.25K0-1
Net PPE purchase and sale -----------3.25K--0---1------------
Cash from discontinued investing activities
Investing cash flow -----------3.25K--0---1------------
Financing cash flow
Cash flow from continuing financing activities 0-99.99%29811.9M-12.5K6.51M0968.80%5.41M506.04K
Net issuance payments of debt --0--0---250K--0--0--0-150.15%-250K--498.54K
Net common stock issuance --0--0--11.9M---12.5K--6.51M--072,014.33%5.41M--7.5K
Proceeds from stock option exercised by employees --0-99.88%298--250K--0--0--0--250K----
Cash from discontinued financing activities
Financing cash flow --0-99.99%298--11.9M---12.5K--6.51M--0968.80%5.41M--506.04K
Net cash flow
Beginning cash position 63.00%6.57M25,685.61%8.4M--32.59K--9.11M--3.23M--4.03M--32.59K--0
Current changes in cash -91.50%-1.53M-145.95%-1.84M--8.37M---706.95K--5.88M---798.56K764.25%4M--462.34K
End cash Position 55.96%5.04M63.00%6.57M--8.4M--8.4M--9.11M--3.23M771.30%4.03M--462.34K
Free cash flow -91.50%-1.53M-29.98%-1.84M---3.53M---694.45K---627.78K---798.56K-3,133.01%-1.41M---43.7K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion----------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data